CV Therapeutics, Inc. Key Financial Ratios and Statistics
Financial Ratios and Key Statistics FYE 31-Dec
| Profitability | 2007 | Leverage | 2007 |
| Net Inc/Comm Equity | -0.17 | Total Liab/Total Assets | 1.72 |
| Net Inc/Total Assets | -0.70 | Total Liab/Inv Cap | 2.02 |
| Net Inc/Inv Cap | -0.82 | Total Liab/Comm Equity | 0.41 |
| Pretax Inc/Net Sales | -2.19 | Interest Coverage Ratio | -13.28 |
| Net Inc/Net Sales | -2.19 | Curr Debt/Equity | NA |
| Cash Flow/Net Sales | -1.96 | LTD/Equity | -2.15 |
| SG&A/NetSales | 1.84 | Total Debt/Equity | -2.15 |
| Asset Utilization | Liquidity | ||
| Net Receivables Turnover | 15.36 | Quick Ratio | 4.92 |
| Inventory Turnover | 0.49 | Current Ratio | 5.51 |
| Inventory Day Sales | 0.00 | Net Rec/Curr Assets | 0.03 |
| Net Sales/Work Cap | 0.47 | Inv/Curr Assets | 0.11 |
| Net Sales/PP&E | 4.33 |
CV Therapeutics, Inc. Key Financial Ratios and Statistics